APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Aldosterone Receptor Antagonists

Types
Steroidal Mineralocorticoid Receptor Antagonists · Non-Steroidal Mineralocorticoid Receptor Antagonists
Applications
Hospital Pharmacies · Online Pharmacies · Retail Pharmacies

5 editions22 December 2025

View 5 research editions

Pharma & Healthcare

Sitagliptin Metformin Extended Release Tablets

Types
Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg · Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg
Applications
Hospital · Clinic · Other

5 editions27 December 2025

View 5 research editions

Pharma & Healthcare

Infertility Drugs

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

Types
Gonadotropins · Anti-Estrogens · Other
Applications
Male · Female

5 editions21 December 2025

View 5 research editions
$4,250Single user · USD · Market Outlook & Growth OpportunitiesExplore product: Infertility DrugsCompare research options for Infertility Drugs

Pharma & Healthcare

Liraglutide

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related…

Types
Pills · Liquid
Applications
Hospital · Drug Store

5 editions21 December 2025

View 5 research editions
APO Research, Inc.